Description: Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Home Page: www.jnj.com
JNJ Technical Analysis
One Johnson & Johnson Plaza
New Brunswick,
NJ
08933
United States
Phone:
732 524 0400
Officers
Name | Title |
---|---|
Mr. Alex Gorsky | Exec. Chairman |
Mr. Joaquin Duato | CEO & Director |
Mr. Joseph J. Wolk CPA | Exec. VP & CFO |
Ms. Jennifer L. Taubert | Exec. VP & Worldwide Chairman of Pharmaceuticals |
Mr. Robert J. Decker Jr. | Controller & Chief Accounting Officer |
Mr. James Swanson | Exec. VP & Chief Information Officer |
Ms. Jessica Moore | VP of Investor Relations |
Mr. Dirk Brinckman | Chief Compliance Officer |
Ms. Elizabeth Forminard | Exec. VP & Gen. Counsel |
Dr. Peter M. Fasolo Ph.D. | Exec. VP & Chief HR Officer |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 16.8919 |
---|---|
Trailing PE: | 23.9863 |
Price-to-Book MRQ: | 6.1592 |
Price-to-Sales TTM: | 4.8935 |
IPO Date: | 1944-09-24 |
Fiscal Year End: | December |
Full Time Employees: | 141700 |